Skip to main content

Kazimi A J's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed May 9, 2025

Accession no.
0001628280-25-024349
Filed
May 9, 2025
Trade date
Apr 1-30, 2025
Filing delay
38 daysLate
Rule 10b5-1 plan
Checked

This filing lists 21 non-derivative transactions and 0 derivative transactions. Open-market purchases total $833.3. It was filed 38 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kazimi A JCIK 0001075050Director, Officer (Chairman and CEO), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 1, 2025Common StockPPurchaseAcquired+8$4.24+$33.925,698,914Direct
Apr 2, 2025Common StockPPurchaseAcquired+8$4.39+$35.125,698,922Direct
Apr 3, 2025Common StockPPurchaseAcquired+8$4.21+$33.685,698,930Direct
Apr 4, 2025Common StockPPurchaseAcquired+8$4.23+$33.845,698,938Direct
Apr 7, 2025Common StockPPurchaseAcquired+8$4.19+$33.525,698,946Direct
Apr 8, 2025Common StockPPurchaseAcquired+8$4.14+$33.125,698,954Direct
Apr 9, 2025Common StockPPurchaseAcquired+8$4.09+$32.725,698,962Direct
Apr 10, 2025Common StockPPurchaseAcquired+8$4.01+$32.085,698,970Direct
Apr 11, 2025Common StockPPurchaseAcquired+8$4.02+$32.165,698,978Direct
Apr 14, 2025Common StockPPurchaseAcquired+10$4.03+$40.35,698,988Direct
Apr 15, 2025Common StockPPurchaseAcquired+10$4.14+$41.45,698,998Direct
Apr 16, 2025Common StockPPurchaseAcquired+10$4.23+$42.35,699,008Direct
Apr 17, 2025Common StockPPurchaseAcquired+10$4.61+$46.15,699,018Direct
Apr 21, 2025Common StockPPurchaseAcquired+10$4.79+$47.95,699,028Direct
Apr 22, 2025Common StockPPurchaseAcquired+10$4.74+$47.45,699,038Direct
Apr 23, 2025Common StockPPurchaseAcquired+10$5.01+$50.15,699,048Direct
Apr 24, 2025Common StockPPurchaseAcquired+10$5.12+$51.25,699,058Direct
Apr 25, 2025Common StockPPurchaseAcquired+10$4.94+$49.45,699,068Direct
Apr 28, 2025Common StockPPurchaseAcquired+8$4.91+$39.285,699,076Direct
Apr 29, 2025Common StockPPurchaseAcquired+8$4.93+$39.445,699,084Direct
Apr 30, 2025Common StockPPurchaseAcquired+8$4.79+$38.325,699,092Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)